“Our study suggests that when emergency medical services incorporate members of the public into their systems, cardiac arrest victims are more likely to survive,” said study author Dr Martin Jonsson (Karolinska Institute, Sweden).
Lay-responder systems (e.g. dispatch of the public to a cardiac arrest) are increasingly implemented around Europe, in particular in indications where time is of key importance. Previously, studies have found an association between these systems and survival after out-of-hospital cardiac arrest. A Swedish study including 8,513 cardiac arrests at 4 different study sites (i.e. 2 in Sweden, 1 in the Netherlands, and 1 in Switzerland) supported the usefulness of this approach.
The study included all out-of-hospital cardiac arrests occurring in 2016 through 2019 in 4 areas. Data from the 2 most populous regions in Sweden (i.e. Stockholm, Västra Götaland) were collected from the Swedish cardiopulmonary resuscitation (CPR) register. Information from North Holland, the Netherlands, was obtained from the ARREST database, and the Ticino Cardiac Arrest Registry was used for Ticino, Switzerland.
The system for dispatch of lay responders worked as follows: the public could sign up as lay responders via a mobile phone app/internet. They were then registered in a database and the system tracks their location. When the dispatch centre receives a call about a cardiac arrest, the dispatcher can activate the system. If lay responders are near the cardiac arrest location, they receive a notification from the app with instructions to run and perform CPR or find an automated external defibrillator (AED).
Activation of lay-responders was compared with a control group regarding the use of CPR, use of AEDs, and 30-day survival following a cardiac arrest in the community. The analyses were adjusted for age, sex, location, witnessed status, emergency medical services response time, and time of day.
In 3,410 of a total of 8,513 cases, lay responders were dispatched to the victim using a smartphone application, while a lay responder was not dispatched in 5,103 cases. When lay responders were dispatched, there was a 28% higher chance of CPR (risk ratio [RR] 1.28; 95% CI 1.12–1.45; P=0.0002), and a 56% higher chance of AED use (RR 1.56; 95% CI 1.02–2.39; P=0.0390). “Most importantly, we saw a 28% higher likelihood of being alive at 30 days,” Dr Jonsson said during the presentation (95% CI 1.10–1.48; P=0.0012).
“Our study demonstrates the benefits of including the general public in the emergency response to a suspected cardiac arrest. Every second counts in these situations and lives can be saved with rapid use of AEDs and CPR,” Dr Jonsson concluded.
- Jonsson M. Dispatch of lay-responders is associated with bystander cardiopulmonary resuscitation, bystander defibrillation and 30-day survival following an out-of-hospital cardiac arrest. ESC Congress 2021, 27–30 August.
- Jonsson M. Dispatch of lay-responders is associated with bystander cardiopulmonary resuscitation, bystander defibrillation and 30-day survival following an out-of-hospital cardiac arrest. Press conference, ESC Congress 2021, 27–30 August.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« Rivaroxaban improves clinical outcomes in discharged COVID-19 patients Next Article
Breathing problems: the most frequently reported symptom before cardiac arrest »
« Rivaroxaban improves clinical outcomes in discharged COVID-19 patients Next Article
Breathing problems: the most frequently reported symptom before cardiac arrest »
Table of Contents: ESC 2021
Featured articles
2021 ESC Clinical Practice Guidelines
2021 ESC Guidelines on Heart Failure
2021 ESC/EACTS Guidelines on Valvular Heart Disease
2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy
2021 ESC Guidelines on Cardiovascular Disease Prevention
Best of the Hotline Sessions
Empagliflozin: First drug with clear benefit in HFpEF patients
CardioMEMS: neutral outcome but possible benefit prior to COVID-19
Cardiac arrest without ST-elevation: instant angiogram does not improve mortality
Older hypertensive patients benefit from intensive blood pressure control
Antagonising the mineralocorticoid receptor beneficial for patients with diabetes and CKD
Late-Breaking Science in Heart Failure
Valsartan seems to attenuate hypertrophic cardiomyopathy progression
Dapagliflozin reduces incidence of sudden death in HFrEF patients
Late-Breaking Science in Hypertension
Smartphone app improves BP control independent of age, sex, and BMI
QUARTET demonstrates that simplicity is key in BP control
Salt substitutes: a successful strategy to improve blood pressure
Late-Breaking Science in Prevention
NATURE-PCSK9: Vaccine-like strategy successful in lowering CV events
Polypill: A successful tool in primary prevention
Important Results in Special Populations
VOYAGER PAD: Fragile or diabetic patients also benefit from rivaroxaban
COVID-19 and the Heart
Rivaroxaban improves clinical outcomes in discharged COVID-19 patients
COVID-19: Thromboembolic risk reduction with therapeutic heparin dosing
Long COVID symptoms – Is ongoing cardiac damage the culprit?
ESC Spotlight of the Year 2021: Sudden Cardiac Death
Breathing problems: the most frequently reported symptom before cardiac arrest
Lay responders can improve survival in out-of-hospital cardiac arrest
Related Articles
October 26, 2021
QUARTET demonstrates that simplicity is key in BP control
October 26, 2021
2021 ESC Guidelines on Heart Failure
October 26, 2021
Polypill: A successful tool in primary prevention
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com